nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.055	0.0735	CbGbCtD
Cilostazol—CYP3A7—Tamoxifen—pancreatic cancer	0.055	0.0735	CbGbCtD
Cilostazol—CYP3A7—Irinotecan—pancreatic cancer	0.0422	0.0565	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0422	0.0565	CbGbCtD
Cilostazol—CYP3A5—Tamoxifen—pancreatic cancer	0.0413	0.0552	CbGbCtD
Cilostazol—CYP1A2—Dacarbazine—pancreatic cancer	0.0386	0.0516	CbGbCtD
Cilostazol—CYP3A5—Erlotinib—pancreatic cancer	0.0351	0.0469	CbGbCtD
Cilostazol—CYP2C19—Tamoxifen—pancreatic cancer	0.0333	0.0445	CbGbCtD
Cilostazol—CYP3A5—Irinotecan—pancreatic cancer	0.0317	0.0424	CbGbCtD
Cilostazol—CYP3A7—Docetaxel—pancreatic cancer	0.031	0.0414	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.031	0.0414	CbGbCtD
Cilostazol—CYP3A7—Sunitinib—pancreatic cancer	0.0308	0.0412	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0308	0.0412	CbGbCtD
Cilostazol—CYP1A2—Tamoxifen—pancreatic cancer	0.0307	0.041	CbGbCtD
Cilostazol—CYP1A2—Erlotinib—pancreatic cancer	0.0261	0.0349	CbGbCtD
Cilostazol—CYP2D6—Tamoxifen—pancreatic cancer	0.0253	0.0338	CbGbCtD
Cilostazol—CYP3A5—Docetaxel—pancreatic cancer	0.0232	0.031	CbGbCtD
Cilostazol—CYP3A5—Sunitinib—pancreatic cancer	0.0231	0.0309	CbGbCtD
Cilostazol—CYP1A2—Fluorouracil—pancreatic cancer	0.0226	0.0302	CbGbCtD
Cilostazol—CYP2D6—Erlotinib—pancreatic cancer	0.0215	0.0288	CbGbCtD
Cilostazol—CYP3A4—Tamoxifen—pancreatic cancer	0.0161	0.0215	CbGbCtD
Cilostazol—CYP3A4—Erlotinib—pancreatic cancer	0.0137	0.0183	CbGbCtD
Cilostazol—CYP3A4—Irinotecan—pancreatic cancer	0.0124	0.0165	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—pancreatic cancer	0.0106	0.0142	CbGbCtD
Cilostazol—CYP3A4—Docetaxel—pancreatic cancer	0.00905	0.0121	CbGbCtD
Cilostazol—CYP3A4—Sunitinib—pancreatic cancer	0.00901	0.012	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—pancreatic cancer	0.00675	0.00902	CbGbCtD
Cilostazol—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000186	0.000737	CcSEcCtD
Cilostazol—Pain—Gemcitabine—pancreatic cancer	0.000185	0.000735	CcSEcCtD
Cilostazol—Nausea—Erlotinib—pancreatic cancer	0.000185	0.000735	CcSEcCtD
Cilostazol—Decreased appetite—Fluorouracil—pancreatic cancer	0.000185	0.000735	CcSEcCtD
Cilostazol—Diarrhoea—Sunitinib—pancreatic cancer	0.000185	0.000733	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000184	0.00073	CcSEcCtD
Cilostazol—Feeling abnormal—Irinotecan—pancreatic cancer	0.000183	0.000727	CcSEcCtD
Cilostazol—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000183	0.000726	CcSEcCtD
Cilostazol—Asthma—Epirubicin—pancreatic cancer	0.000182	0.000724	CcSEcCtD
Cilostazol—Influenza—Epirubicin—pancreatic cancer	0.000182	0.000724	CcSEcCtD
Cilostazol—Back pain—Docetaxel—pancreatic cancer	0.000182	0.000723	CcSEcCtD
Cilostazol—Pain—Fluorouracil—pancreatic cancer	0.000182	0.000723	CcSEcCtD
Cilostazol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000182	0.000722	CcSEcCtD
Cilostazol—Muscle spasms—Docetaxel—pancreatic cancer	0.000181	0.000719	CcSEcCtD
Cilostazol—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00018	0.000715	CcSEcCtD
Cilostazol—Dry skin—Doxorubicin—pancreatic cancer	0.000179	0.00071	CcSEcCtD
Cilostazol—Dizziness—Sunitinib—pancreatic cancer	0.000179	0.000709	CcSEcCtD
Cilostazol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000179	0.000709	CcSEcCtD
Cilostazol—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000178	0.000708	CcSEcCtD
Cilostazol—Angina pectoris—Epirubicin—pancreatic cancer	0.000178	0.000705	CcSEcCtD
Cilostazol—Abdominal pain—Irinotecan—pancreatic cancer	0.000176	0.000698	CcSEcCtD
Cilostazol—Body temperature increased—Irinotecan—pancreatic cancer	0.000176	0.000698	CcSEcCtD
Cilostazol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000176	0.000697	CcSEcCtD
Cilostazol—Bronchitis—Epirubicin—pancreatic cancer	0.000175	0.000696	CcSEcCtD
Cilostazol—Anaemia—Docetaxel—pancreatic cancer	0.000174	0.000691	CcSEcCtD
Cilostazol—Pancytopenia—Epirubicin—pancreatic cancer	0.000173	0.000687	CcSEcCtD
Cilostazol—Gastritis—Doxorubicin—pancreatic cancer	0.000173	0.000686	CcSEcCtD
Cilostazol—Vomiting—Sunitinib—pancreatic cancer	0.000172	0.000681	CcSEcCtD
Cilostazol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000171	0.00068	CcSEcCtD
Cilostazol—Rash—Sunitinib—pancreatic cancer	0.00017	0.000676	CcSEcCtD
Cilostazol—Dermatitis—Sunitinib—pancreatic cancer	0.00017	0.000675	CcSEcCtD
Cilostazol—Urticaria—Fluorouracil—pancreatic cancer	0.000169	0.000672	CcSEcCtD
Cilostazol—Headache—Sunitinib—pancreatic cancer	0.000169	0.000671	CcSEcCtD
Cilostazol—Syncope—Docetaxel—pancreatic cancer	0.000169	0.00067	CcSEcCtD
Cilostazol—Influenza—Doxorubicin—pancreatic cancer	0.000169	0.00067	CcSEcCtD
Cilostazol—Asthma—Doxorubicin—pancreatic cancer	0.000169	0.00067	CcSEcCtD
Cilostazol—Leukopenia—Docetaxel—pancreatic cancer	0.000169	0.000669	CcSEcCtD
Cilostazol—Pollakiuria—Epirubicin—pancreatic cancer	0.000168	0.000669	CcSEcCtD
Cilostazol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000168	0.000668	CcSEcCtD
Cilostazol—Palpitations—Docetaxel—pancreatic cancer	0.000166	0.000661	CcSEcCtD
Cilostazol—Loss of consciousness—Docetaxel—pancreatic cancer	0.000166	0.000657	CcSEcCtD
Cilostazol—Cough—Docetaxel—pancreatic cancer	0.000164	0.000652	CcSEcCtD
Cilostazol—Angina pectoris—Doxorubicin—pancreatic cancer	0.000164	0.000652	CcSEcCtD
Cilostazol—Pneumonia—Epirubicin—pancreatic cancer	0.000164	0.000649	CcSEcCtD
Cilostazol—Hypertension—Docetaxel—pancreatic cancer	0.000163	0.000645	CcSEcCtD
Cilostazol—Bronchitis—Doxorubicin—pancreatic cancer	0.000162	0.000644	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000161	0.00064	CcSEcCtD
Cilostazol—Myalgia—Docetaxel—pancreatic cancer	0.00016	0.000637	CcSEcCtD
Cilostazol—Arthralgia—Docetaxel—pancreatic cancer	0.00016	0.000637	CcSEcCtD
Cilostazol—Chest pain—Docetaxel—pancreatic cancer	0.00016	0.000637	CcSEcCtD
Cilostazol—Nausea—Sunitinib—pancreatic cancer	0.00016	0.000637	CcSEcCtD
Cilostazol—Pancytopenia—Doxorubicin—pancreatic cancer	0.00016	0.000636	CcSEcCtD
Cilostazol—Asthenia—Irinotecan—pancreatic cancer	0.00016	0.000633	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000159	0.000632	CcSEcCtD
Cilostazol—Jaundice—Epirubicin—pancreatic cancer	0.000158	0.000629	CcSEcCtD
Cilostazol—Conjunctivitis—Epirubicin—pancreatic cancer	0.000158	0.000627	CcSEcCtD
Cilostazol—Urinary tract infection—Epirubicin—pancreatic cancer	0.000158	0.000627	CcSEcCtD
Cilostazol—Pollakiuria—Doxorubicin—pancreatic cancer	0.000156	0.000619	CcSEcCtD
Cilostazol—Asthenia—Gemcitabine—pancreatic cancer	0.000155	0.000617	CcSEcCtD
Cilostazol—Haematuria—Epirubicin—pancreatic cancer	0.000155	0.000615	CcSEcCtD
Cilostazol—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000154	0.00061	CcSEcCtD
Cilostazol—Oedema—Docetaxel—pancreatic cancer	0.000154	0.00061	CcSEcCtD
Cilostazol—Epistaxis—Epirubicin—pancreatic cancer	0.000153	0.000609	CcSEcCtD
Cilostazol—Pruritus—Gemcitabine—pancreatic cancer	0.000153	0.000608	CcSEcCtD
Cilostazol—Infection—Docetaxel—pancreatic cancer	0.000153	0.000606	CcSEcCtD
Cilostazol—Sinusitis—Epirubicin—pancreatic cancer	0.000153	0.000605	CcSEcCtD
Cilostazol—Diarrhoea—Irinotecan—pancreatic cancer	0.000152	0.000604	CcSEcCtD
Cilostazol—Agranulocytosis—Epirubicin—pancreatic cancer	0.000152	0.000602	CcSEcCtD
Cilostazol—Pneumonia—Doxorubicin—pancreatic cancer	0.000151	0.000601	CcSEcCtD
Cilostazol—Shock—Docetaxel—pancreatic cancer	0.000151	0.0006	CcSEcCtD
Cilostazol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000151	0.000598	CcSEcCtD
Cilostazol—Pruritus—Fluorouracil—pancreatic cancer	0.000151	0.000598	CcSEcCtD
Cilostazol—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000151	0.000597	CcSEcCtD
Cilostazol—Tachycardia—Docetaxel—pancreatic cancer	0.00015	0.000596	CcSEcCtD
Cilostazol—Skin disorder—Docetaxel—pancreatic cancer	0.000149	0.000593	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000149	0.000592	CcSEcCtD
Cilostazol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000148	0.000588	CcSEcCtD
Cilostazol—Dizziness—Irinotecan—pancreatic cancer	0.000147	0.000584	CcSEcCtD
Cilostazol—Haemoglobin—Epirubicin—pancreatic cancer	0.000147	0.000582	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—pancreatic cancer	0.000147	0.000582	CcSEcCtD
Cilostazol—Anorexia—Docetaxel—pancreatic cancer	0.000147	0.000582	CcSEcCtD
Cilostazol—Rhinitis—Epirubicin—pancreatic cancer	0.000146	0.000581	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000146	0.00058	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000146	0.00058	CcSEcCtD
Cilostazol—Haemorrhage—Epirubicin—pancreatic cancer	0.000146	0.000579	CcSEcCtD
Cilostazol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000146	0.000578	CcSEcCtD
Cilostazol—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000145	0.000576	CcSEcCtD
Cilostazol—Pharyngitis—Epirubicin—pancreatic cancer	0.000145	0.000575	CcSEcCtD
Cilostazol—Oedema peripheral—Epirubicin—pancreatic cancer	0.000144	0.000571	CcSEcCtD
Cilostazol—Hypotension—Docetaxel—pancreatic cancer	0.000144	0.00057	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—pancreatic cancer	0.000143	0.000569	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000142	0.000565	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—pancreatic cancer	0.000142	0.000563	CcSEcCtD
Cilostazol—Vomiting—Irinotecan—pancreatic cancer	0.000141	0.000561	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—pancreatic cancer	0.000141	0.00056	CcSEcCtD
Cilostazol—Dizziness—Fluorouracil—pancreatic cancer	0.000141	0.000559	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00014	0.000557	CcSEcCtD
Cilostazol—Rash—Irinotecan—pancreatic cancer	0.00014	0.000557	CcSEcCtD
Cilostazol—Dermatitis—Irinotecan—pancreatic cancer	0.00014	0.000556	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00014	0.000556	CcSEcCtD
Cilostazol—Headache—Irinotecan—pancreatic cancer	0.000139	0.000553	CcSEcCtD
Cilostazol—Insomnia—Docetaxel—pancreatic cancer	0.000139	0.000552	CcSEcCtD
Cilostazol—Paraesthesia—Docetaxel—pancreatic cancer	0.000138	0.000548	CcSEcCtD
Cilostazol—Erythema multiforme—Epirubicin—pancreatic cancer	0.000138	0.000548	CcSEcCtD
Cilostazol—Vomiting—Gemcitabine—pancreatic cancer	0.000138	0.000547	CcSEcCtD
Cilostazol—Dyspnoea—Docetaxel—pancreatic cancer	0.000137	0.000544	CcSEcCtD
Cilostazol—Rash—Gemcitabine—pancreatic cancer	0.000137	0.000542	CcSEcCtD
Cilostazol—Dermatitis—Gemcitabine—pancreatic cancer	0.000136	0.000542	CcSEcCtD
Cilostazol—Tinnitus—Epirubicin—pancreatic cancer	0.000136	0.00054	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—pancreatic cancer	0.000136	0.000539	CcSEcCtD
Cilostazol—Headache—Gemcitabine—pancreatic cancer	0.000136	0.000539	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—pancreatic cancer	0.000135	0.000538	CcSEcCtD
Cilostazol—Vomiting—Fluorouracil—pancreatic cancer	0.000135	0.000538	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—pancreatic cancer	0.000135	0.000537	CcSEcCtD
Cilostazol—Dyspepsia—Docetaxel—pancreatic cancer	0.000135	0.000537	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—pancreatic cancer	0.000135	0.000536	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000134	0.000533	CcSEcCtD
Cilostazol—Rash—Fluorouracil—pancreatic cancer	0.000134	0.000533	CcSEcCtD
Cilostazol—Dermatitis—Fluorouracil—pancreatic cancer	0.000134	0.000533	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—pancreatic cancer	0.000134	0.000532	CcSEcCtD
Cilostazol—Decreased appetite—Docetaxel—pancreatic cancer	0.000134	0.00053	CcSEcCtD
Cilostazol—Headache—Fluorouracil—pancreatic cancer	0.000133	0.00053	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000133	0.000528	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000133	0.000527	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—pancreatic cancer	0.000132	0.000526	CcSEcCtD
Cilostazol—Nausea—Irinotecan—pancreatic cancer	0.000132	0.000524	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000132	0.000522	CcSEcCtD
Cilostazol—Pain—Docetaxel—pancreatic cancer	0.000131	0.000522	CcSEcCtD
Cilostazol—Chills—Epirubicin—pancreatic cancer	0.000131	0.00052	CcSEcCtD
Cilostazol—Nausea—Gemcitabine—pancreatic cancer	0.000129	0.000511	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000128	0.000507	CcSEcCtD
Cilostazol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000127	0.000503	CcSEcCtD
Cilostazol—Nausea—Fluorouracil—pancreatic cancer	0.000127	0.000502	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—pancreatic cancer	0.000126	0.0005	CcSEcCtD
Cilostazol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000126	0.000499	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000125	0.000497	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—pancreatic cancer	0.000125	0.000497	CcSEcCtD
Cilostazol—Back pain—Epirubicin—pancreatic cancer	0.000123	0.000488	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—pancreatic cancer	0.000123	0.000486	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—pancreatic cancer	0.000122	0.000485	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000122	0.000483	CcSEcCtD
Cilostazol—Body temperature increased—Docetaxel—pancreatic cancer	0.000122	0.000482	CcSEcCtD
Cilostazol—Abdominal pain—Docetaxel—pancreatic cancer	0.000122	0.000482	CcSEcCtD
Cilostazol—Chills—Doxorubicin—pancreatic cancer	0.000121	0.000481	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000118	0.000468	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—pancreatic cancer	0.000117	0.000466	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—pancreatic cancer	0.000116	0.00046	CcSEcCtD
Cilostazol—Malaise—Epirubicin—pancreatic cancer	0.000115	0.000455	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—pancreatic cancer	0.000114	0.000453	CcSEcCtD
Cilostazol—Syncope—Epirubicin—pancreatic cancer	0.000114	0.000452	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—pancreatic cancer	0.000114	0.000451	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—pancreatic cancer	0.000114	0.000451	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—pancreatic cancer	0.000113	0.000449	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—pancreatic cancer	0.000112	0.000446	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—pancreatic cancer	0.000112	0.000443	CcSEcCtD
Cilostazol—Cough—Epirubicin—pancreatic cancer	0.000111	0.00044	CcSEcCtD
Cilostazol—Asthenia—Docetaxel—pancreatic cancer	0.00011	0.000438	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—pancreatic cancer	0.00011	0.000435	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000109	0.000433	CcSEcCtD
Cilostazol—Pruritus—Docetaxel—pancreatic cancer	0.000109	0.000432	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—pancreatic cancer	0.000109	0.000431	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—pancreatic cancer	0.000108	0.000429	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—pancreatic cancer	0.000108	0.000429	CcSEcCtD
Cilostazol—Arthralgia—Epirubicin—pancreatic cancer	0.000108	0.000429	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—pancreatic cancer	0.000108	0.000428	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000107	0.000426	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—pancreatic cancer	0.000107	0.000424	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—pancreatic cancer	0.000106	0.000421	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—pancreatic cancer	0.000106	0.000419	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—pancreatic cancer	0.000105	0.000418	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—pancreatic cancer	0.000105	0.000418	CcSEcCtD
Cilostazol—Diarrhoea—Docetaxel—pancreatic cancer	0.000105	0.000417	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—pancreatic cancer	0.000104	0.000412	CcSEcCtD
Cilostazol—Oedema—Epirubicin—pancreatic cancer	0.000104	0.000412	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000103	0.00041	CcSEcCtD
Cilostazol—Infection—Epirubicin—pancreatic cancer	0.000103	0.000409	CcSEcCtD
Cilostazol—Cough—Doxorubicin—pancreatic cancer	0.000103	0.000407	CcSEcCtD
Cilostazol—Shock—Epirubicin—pancreatic cancer	0.000102	0.000405	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—pancreatic cancer	0.000102	0.000404	CcSEcCtD
Cilostazol—Dizziness—Docetaxel—pancreatic cancer	0.000102	0.000404	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000102	0.000403	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—pancreatic cancer	0.000101	0.000403	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—pancreatic cancer	0.000101	0.000402	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—pancreatic cancer	0.000101	0.0004	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—pancreatic cancer	0.0001	0.000397	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—pancreatic cancer	0.0001	0.000397	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—pancreatic cancer	0.0001	0.000397	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—pancreatic cancer	9.97e-05	0.000396	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	9.94e-05	0.000395	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—pancreatic cancer	9.89e-05	0.000392	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—pancreatic cancer	9.88e-05	0.000392	CcSEcCtD
Cilostazol—Vomiting—Docetaxel—pancreatic cancer	9.77e-05	0.000388	CcSEcCtD
Cilostazol—Rash—Docetaxel—pancreatic cancer	9.69e-05	0.000385	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—pancreatic cancer	9.69e-05	0.000385	CcSEcCtD
Cilostazol—Dermatitis—Docetaxel—pancreatic cancer	9.68e-05	0.000384	CcSEcCtD
Cilostazol—Headache—Docetaxel—pancreatic cancer	9.63e-05	0.000382	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—pancreatic cancer	9.59e-05	0.000381	CcSEcCtD
Cilostazol—Infection—Doxorubicin—pancreatic cancer	9.53e-05	0.000378	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	9.45e-05	0.000375	CcSEcCtD
Cilostazol—Shock—Doxorubicin—pancreatic cancer	9.44e-05	0.000375	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—pancreatic cancer	9.41e-05	0.000373	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.39e-05	0.000373	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—pancreatic cancer	9.38e-05	0.000372	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—pancreatic cancer	9.36e-05	0.000372	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—pancreatic cancer	9.32e-05	0.00037	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—pancreatic cancer	9.31e-05	0.00037	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—pancreatic cancer	9.24e-05	0.000367	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—pancreatic cancer	9.15e-05	0.000363	CcSEcCtD
Cilostazol—Nausea—Docetaxel—pancreatic cancer	9.13e-05	0.000362	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—pancreatic cancer	9.13e-05	0.000362	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—pancreatic cancer	9.01e-05	0.000358	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—pancreatic cancer	8.97e-05	0.000356	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	8.95e-05	0.000355	CcSEcCtD
Cilostazol—Pain—Epirubicin—pancreatic cancer	8.87e-05	0.000352	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.74e-05	0.000347	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—pancreatic cancer	8.68e-05	0.000344	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—pancreatic cancer	8.62e-05	0.000342	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—pancreatic cancer	8.55e-05	0.00034	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—pancreatic cancer	8.54e-05	0.000339	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—pancreatic cancer	8.48e-05	0.000337	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—pancreatic cancer	8.45e-05	0.000335	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—pancreatic cancer	8.34e-05	0.000331	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.28e-05	0.000329	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—pancreatic cancer	8.24e-05	0.000327	CcSEcCtD
Cilostazol—Pain—Doxorubicin—pancreatic cancer	8.2e-05	0.000326	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—pancreatic cancer	8.2e-05	0.000325	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—pancreatic cancer	8.2e-05	0.000325	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—pancreatic cancer	7.91e-05	0.000314	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.85e-05	0.000311	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—pancreatic cancer	7.62e-05	0.000303	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—pancreatic cancer	7.58e-05	0.000301	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—pancreatic cancer	7.58e-05	0.000301	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—pancreatic cancer	7.44e-05	0.000295	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—pancreatic cancer	7.34e-05	0.000291	CcSEcCtD
Cilostazol—Diarrhoea—Epirubicin—pancreatic cancer	7.09e-05	0.000282	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—pancreatic cancer	6.88e-05	0.000273	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—pancreatic cancer	6.86e-05	0.000272	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—pancreatic cancer	6.79e-05	0.000269	CcSEcCtD
Cilostazol—Vomiting—Epirubicin—pancreatic cancer	6.59e-05	0.000262	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—pancreatic cancer	6.56e-05	0.000261	CcSEcCtD
Cilostazol—Rash—Epirubicin—pancreatic cancer	6.54e-05	0.000259	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—pancreatic cancer	6.53e-05	0.000259	CcSEcCtD
Cilostazol—Headache—Epirubicin—pancreatic cancer	6.5e-05	0.000258	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—pancreatic cancer	6.34e-05	0.000252	CcSEcCtD
Cilostazol—Nausea—Epirubicin—pancreatic cancer	6.16e-05	0.000244	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—pancreatic cancer	6.1e-05	0.000242	CcSEcCtD
Cilostazol—Rash—Doxorubicin—pancreatic cancer	6.05e-05	0.00024	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—pancreatic cancer	6.04e-05	0.00024	CcSEcCtD
Cilostazol—Headache—Doxorubicin—pancreatic cancer	6.01e-05	0.000239	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—pancreatic cancer	5.7e-05	0.000226	CcSEcCtD
